These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36357014)

  • 41. The NCDR Left Atrial Appendage Occlusion Registry.
    Freeman JV; Varosy P; Price MJ; Slotwiner D; Kusumoto FM; Rammohan C; Kavinsky CJ; Turi ZG; Akar J; Koutras C; Curtis JP; Masoudi FA
    J Am Coll Cardiol; 2020 Apr; 75(13):1503-1518. PubMed ID: 32238316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
    Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
    Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
    Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device.
    Pastormerlo LE; Tondo C; Fassini G; Nicosia A; Ronco F; Contarini M; Giacchi G; Grasso C; Casu G; Romeo MR; Mazzone P; Limite L; Caramanno G; Geraci S; Pagnotta P; Chiarito M; Tamburino C; Berti S
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC).
    Kleinecke C; Yu J; Neef P; Buffle E; de Marchi S; Fuerholz M; Nietlispach F; Valgimigli M; Streit SR; Fankhauser M; Duenninger E; Windecker S; Meier B; Gloekler S
    Europace; 2020 Jun; 22(6):916-923. PubMed ID: 32003774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Preprocedure Imaging for Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
    Clarke JD; Higgins AY; Wang Y; Faridi KF; Curtis JA; Freeman JV; Friedman DJ
    JACC Cardiovasc Interv; 2023 Jun; 16(11):1317-1328. PubMed ID: 37316143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
    Su F; Gao C; Liu J; Ning Z; He B; Liu Y; Xu Y; Yang B; Li Y; Zhang J; Zhao X; Zhang Y; Hu H; Du X; Xie R; Zhou L; Zeng J; Ruan Z; Liu H; Guo J; Wang R; Garg S; Soliman O; Holmes DR; Serruys PW; Tao L
    JAMA Netw Open; 2022 May; 5(5):e2214594. PubMed ID: 35639378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study.
    Betts TR; Grygier M; Nielsen Kudsk JE; Schmitz T; Sandri M; Casu G; Bergmann M; Hildick-Smith D; Christen T; Allocco DJ;
    Europace; 2023 Mar; 25(3):914-921. PubMed ID: 36734247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion.
    Faridi KF; Ong EL; Zimmerman S; Varosy PD; Friedman DJ; Hsu JC; Kusumoto F; Mortazavi BJ; Minges KE; Pereira L; Lakkireddy D; Koutras C; Denton B; Mobayed J; Curtis JP; Freeman JV
    Circ Arrhythm Electrophysiol; 2024 Apr; 17(4):e012424. PubMed ID: 38390713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial.
    Kar S; Doshi SK; Sadhu A; Horton R; Osorio J; Ellis C; Stone J; Shah M; Dukkipati SR; Adler S; Nair DG; Kim J; Wazni O; Price MJ; Asch FM; Holmes DR; Shipley RD; Gordon NT; Allocco DJ; Reddy VY;
    Circulation; 2021 May; 143(18):1754-1762. PubMed ID: 33820423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Left atrial anatomy and patient-related factors associated with adverse outcomes with the watchman device-a real world experience.
    Murarka S; Lazkani M; Moualla S; Verma DR; Pershad A
    J Interv Cardiol; 2017 Apr; 30(2):163-169. PubMed ID: 28256020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
    Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
    J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracardiac echocardiography-guided implantation of the Watchman FLX left atrial appendage closure device.
    Turagam MK; Neuzil P; Petru J; Hala P; Mraz T; Baroch J; Lekesova V; Prokopova M; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):717-725. PubMed ID: 33533089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.